EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Clinical application of PBMCs in breast cancer: detection, treatment evaluation and prognosis

Bo Song, Shixuan Liang, Peng Wu, Xiaomin Li, Qian Gong

Frontiers in Cell and Developmental Biology · 10.12.2025 · 13

DOI: 10.3389/fcell.2025.1721106 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 10.12.2025. Verfasst von Bo Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Radiology, The Affiliated Cancer Hospital of Xiangya School of Medicine/Hunan Cancer Hospital, Central South University, Cha…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) has superseded lung cancer as the most prevalent malignant neoplasm globally, posing a significant threat to human health. Currently, mammography and ultrasonography serve as the primary modalities for early breast cancer screening. However, X-ray examination exhibits low sensitivity, while ultrasonography has a high false positive rate, which can readily lead to overdiagnosis and overtreatment. Peripheral blood mononuclear cells (PBMCs), which are specialized immune cells generated by hematopoietic stem cells (HSCs), actively monitor any indications of infection, foreign invaders, and abnormal or aberrant cells associated with diseases. Given that PBMCs respond to diverse pathophysiological stimuli in the form of immune responses/immune phenotypic changes, the study of the molecular constituents of PBMCs can facilitate a better understanding of the immune process. Simultaneously, as PBMCs can be isolated from peripheral blood and detected in liquid form, they offer a non-invasive and suitable source of biomarkers. The analysis of PBMCs in cancer patients can be utilized for the early screening and diagnosis of breast cancer, as well as for evaluating therapeutic efficacy and prognosis. This article reviews the clinical application of PBMCs in breast cancer, highlighting its advantages and limitations.

Schlagwörter

Stichwörter der Autor:innen

blood detectionbreast cancerefficacy evaluationperipheral mononuclear cells PBMCsprognosis

Autor:innen und Institutionen

  • Department of Diagnostic Radiology, The Affiliated Cancer Hospital of Xiangya School of Medicine/Hunan Cancer Hospital, Central South University, Changsha, Hunan, China.
  • Hunan Provincial Clinical Research Centre for Oncoplastic Surgery, The Affiliated Cancer Hospital of Xiangya School of Medicine/Hunan Cancer Hospital, Central South University, Changsha, Hunan, China.
  • Department of Head and Neck Surgery, The Affiliated Cancer Hospital of Xiangya School of Medicine/Hunan Cancer Hospital, Central South University, Changsha, Hunan, China.
  • Phase I Clinical Trial Center, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Drug Clinical Research Center, The Affiliated Cancer Hospital of Xiangya School of Medicine/Hunan Cancer Hospital, Central South University, Changsha, Hunan, China.

Zitieren

APA

Song, B., Liang, S., Wu, P., Li, X., & Gong, Q. (2025). Clinical application of PBMCs in breast cancer: detection, treatment evaluation and prognosis. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1721106

Vancouver

Song B, Liang S, Wu P, Li X, Gong Q. Clinical application of PBMCs in breast cancer: detection, treatment evaluation and prognosis. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1721106

BibTeX
@article{Song2025,
  author = {Song, Bo and Liang, Shixuan and Wu, Peng and Li, Xiaomin and Gong, Qian},
  title = {Clinical application of PBMCs in breast cancer: detection, treatment evaluation and prognosis},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2025},
  volume = {13},
  doi = {10.3389/fcell.2025.1721106}
}
Kostenlos starten →